Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Apr;99(4):713–716. doi: 10.1111/j.1476-5381.1990.tb12994.x

Hypotensive effects of 8-hydroxy-2-(di-n-propylamino)tetralin and 5-methylurapidil following stereotaxic microinjection into the ventral medulla of the rat.

B Valenta 1, E A Singer 1
PMCID: PMC1917564  PMID: 1972893

Abstract

1. The effects of the 5-HT1a receptor agonists 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and 5-methylurapidil (5-MU) on blood pressure and heart rate were investigated in the anaesthetized normotensive rat after local injection into the ventral medulla (medial part of the area of the B1/B3 cell group). 2. Both 8-OH-DPAT and 5-MU, decreased arterial blood pressure and heart rate. Local injection of the alpha 1-adrenoceptor antagonist prazosin did not affect cardiovascular parameters. 3. Subcutaneous injection of the 5-HT1a receptor antagonists spiroxatrine or spiperone inhibited the cardiovascular response to 8-OH-DPAT and 5-MU. 4. Histological examination showed the injection sites which were associated with cardiovascular responses to the agonists to be contained within the medial part of the area of the B1/B3 cell group, corresponding to the region of the nucleus raphe magnus and pallidus. Injections of agonists into adjacent areas had no effect on blood pressure or heart rate. 5. The results support the hypothesis that activation of somatodendritic 5-HT1a autoreceptors located on 5-hydroxytryptaminergic neurones in the ventral medulla of the rat results in a decrease in blood pressure and heart rate. The region of the B1/B3 cell group is suggested as a possible site for the hypotensive action of 5-HT1a receptor agonists.

Full text

PDF
713

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amendt K., Czachurski J., Dembowsky K., Seller H. Bulbospinal projections to the intermediolateral cell column: a neuroanatomical study. J Auton Nerv Syst. 1979 Oct;1(1):103–107. doi: 10.1016/0165-1838(79)90009-2. [DOI] [PubMed] [Google Scholar]
  2. Aslanian V., Lambas-Senas L., Renaud B. In vivo voltammetry in the B3 group of serotonin neurons of the rat medulla oblongata after drug-induced modifications of arterial pressure. Life Sci. 1988;43(13):1031–1038. doi: 10.1016/0024-3205(88)90197-x. [DOI] [PubMed] [Google Scholar]
  3. Fozard J. R., Mir A. K., Middlemiss D. N. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. J Cardiovasc Pharmacol. 1987 Mar;9(3):328–347. doi: 10.1097/00005344-198703000-00010. [DOI] [PubMed] [Google Scholar]
  4. Franz D. N., Madsen P. W., Peterson R. G., Sangdee C. Functional roles of monoaminergic pathways to sympathetic preganglionic neurons. Clin Exp Hypertens A. 1982;4(4-5):543–562. doi: 10.3109/10641968209061598. [DOI] [PubMed] [Google Scholar]
  5. Gillis R. A., Dretchen K. L., Namath I., Anastasi N., Dias Souza J., Hill K., Browne R. K., Quest J. A. Hypotensive effect of urapidil: CNS site and relative contribution. J Cardiovasc Pharmacol. 1987 Jan;9(1):103–109. [PubMed] [Google Scholar]
  6. Gillis R. A., Hill K. J., Kirby J. S., Quest J. A., Hamosh P., Norman W. P., Kellar K. J. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function. J Pharmacol Exp Ther. 1989 Feb;248(2):851–857. [PubMed] [Google Scholar]
  7. Gross G., Hanft G., Kolassa N. Urapidil and some analogues with hypotensive properties show high affinities for 5-hydroxytryptamine (5-HT) binding sites of the 5-HT1A subtype and for alpha 1-adrenoceptor binding sites. Naunyn Schmiedebergs Arch Pharmacol. 1987 Dec;336(6):597–601. doi: 10.1007/BF00165749. [DOI] [PubMed] [Google Scholar]
  8. Gross G., Hanft G., Rugevics C. 5-Methyl-urapidil discriminates between subtypes of the alpha 1-adrenoceptor. Eur J Pharmacol. 1988 Jul 7;151(2):333–335. doi: 10.1016/0014-2999(88)90819-9. [DOI] [PubMed] [Google Scholar]
  9. Hjorth S., Magnusson T. The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn Schmiedebergs Arch Pharmacol. 1988 Nov;338(5):463–471. doi: 10.1007/BF00179315. [DOI] [PubMed] [Google Scholar]
  10. Kellar K. J., Quest J. A., Spera A. C., Buller A., Conforti A., Dias Souza J., Gillis R. A. Comparative effects of urapidil, prazosin, and clonidine on ligand binding to central nervous system receptors, arterial pressure, and heart rate in experimental animals. Am J Med. 1984 Oct 5;77(4A):87–95. doi: 10.1016/s0002-9343(84)80042-x. [DOI] [PubMed] [Google Scholar]
  11. Laubie M., Drouillat M., Dabiré H., Cherqui C., Schmitt H. Ventrolateral medullary pressor area: site of hypotensive and sympatho-inhibitory effects of (+/-)8-OH-DPAT in anaesthetized dogs. Eur J Pharmacol. 1989 Feb 7;160(3):385–394. doi: 10.1016/0014-2999(89)90094-0. [DOI] [PubMed] [Google Scholar]
  12. Loewy A. D., McKellar S. Serotonergic projections from the ventral medulla to the intermediolateral cell column in the rat. Brain Res. 1981 Apr 27;211(1):146–152. doi: 10.1016/0006-8993(81)90074-3. [DOI] [PubMed] [Google Scholar]
  13. Martin G. E., Lis E. V., Jr Hypotensive action of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) in spontaneously hypertensive rats. Arch Int Pharmacodyn Ther. 1985 Feb;273(2):251–261. [PubMed] [Google Scholar]
  14. McCall R. B., Patel B. N., Harris L. T. Effects of serotonin1 and serotonin2 receptor agonists and antagonists on blood pressure, heart rate and sympathetic nerve activity. J Pharmacol Exp Ther. 1987 Sep;242(3):1152–1159. [PubMed] [Google Scholar]
  15. Middlemiss D. N., Fozard J. R. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol. 1983 May 20;90(1):151–153. doi: 10.1016/0014-2999(83)90230-3. [DOI] [PubMed] [Google Scholar]
  16. Pilowsky P. M., Kapoor V., Minson J. B., West M. J., Chalmers J. P. Spinal cord serotonin release and raised blood pressure after brainstem kainic acid injection. Brain Res. 1986 Feb 26;366(1-2):354–357. doi: 10.1016/0006-8993(86)91318-1. [DOI] [PubMed] [Google Scholar]
  17. Verge D., Daval G., Patey A., Gozlan H., el Mestikawy S., Hamon M. Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. Eur J Pharmacol. 1985 Jul 31;113(3):463–464. doi: 10.1016/0014-2999(85)90099-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES